Domestically produced innovative drug Marsidueptide has been prescribed for the first time in the country.

Reporters learned that Xinda Bio's GLP-1 class weight-loss innovative drug Matideptide was prescribed for the first time in the country at Peking University People's Hospital on July 3. Professor Ji Linong of Peking University People's Hospital prescribed the drug for an overweight patient with fatty liver, marking the official commercialization of the drug nationwide.